Cellectar Biosciences Announces Shane Lea as Chief

FLORHAM PARK, N.J., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused...

Related Keywords

United States ,James Caruso ,Monique Kosse ,Cellectar Biosciences ,Shane Lea ,Allos Therapeutics ,Bachelor Of Business Administration ,Linkedin ,Lifesci Advisors ,Imclone Systems ,Twitter ,Cellectar Biosciences Inc ,Nasdaq ,Novartis ,Abraxis Bioscience ,Exchange Commission ,Facebook ,University Of Louisiana Monroe ,Aventis Oncology ,Business Administration ,Phospholipid Drug Conjugate ,Nasdaq Listing Rule ,Common Stock ,Nasdaq Capital Market ,Sci Advisors ,Nasdaq Clrb ,